Portfolio company
Protuoso Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
InduPro
This biotechnology company develops proximity-based protein therapeutics for patients with cancer and autoimmune diseases.
Arpelos Biosciences
This biotechnology company develops multivalent therapeutics and biologics using protein engineering to treat various diseases for healthcare providers and pharmaceutical patients.
Cold Start Therapeutics
This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.
Catena Bio
This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Modulari-T Biosciences
This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.
ProtOS
This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.
